Myeloma Novel Drug Targets and agents
A novel dual HDAC6 and proteasome inhibitor elicits outstanding cytotoxicity against multiple myeloma
Teng Fang, PhD student
PhD student
State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China., United States